Impact of height and weight on acenocoumarol and phenprocoumon dose needed

Completed

• Conditions: atrial fribrillation; Thrombosis; 10007521; 10014523

• Registration Number: NL-OMON32954
• Lead Sponsor: niversiteit Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 2000

Inclusion Criteria

INR target between 2.5 and 3.5
18 years or older
no participation at vitamin K study (VIKS2A)

Exclusion Criteria

Pregnancy or lactation
Severe cognitive impairment

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The impact of height and weight on the coumarin dose required. This will be<br /><br>investigated with lineair regression.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The dataset will be used as validation of the already developed acenocoumarol<br /><br>and phenrocoumon dosing algorithms.</p><br>